gastroenterology

News in Brief: Infliximab PBS restrictions to be lifted for UC patients; IBD rarely seen Indigenous Australians; Hospitalised patients face sleep disruption due to noise

Infliximab PBS restrictions to be lifted for UC patients The Pharmaceutical Benefits Advisory Committee has approved a request from gastroenterologists to allow patients treated with PBS-subsidised infliximab under the acute severe ulcerative colitis (ASUC) listing to subsequently transition to PBS-subsidised infliximab for the treatment of moderate to severe ulcerative colitis (MSUC) without having to demonstrate ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic